CXCL2 and neoplasm: Furthermore, we identify recruitment of immunosuppressive Gr1+ myeloid cells via tumor cell expression of CXCL1, CXCL2, and CXCL8 (CXCR2 ligands) expression, which were substantially reduced with MEKi or CXCR2 blockade.